| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MET | Common Stock | Award | $2,789 | +42 | +0.22% | $66.41 | 19,111 | 14 Sep 2022 | Direct | F1 |
| holding | MET | Common Stock | 87 | 14 Sep 2022 | by David L. Herzog Trust |
| Id | Content |
|---|---|
| F1 | Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. |